Related references
Note: Only part of the references are listed.Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer
L. K. Nottingham et al.
ONCOGENE (2014)
Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
Laura Bergada et al.
PLOS ONE (2014)
First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors
Cristiana Sessa et al.
CLINICAL CANCER RESEARCH (2013)
PI3K Pathway Dependencies in Endometrioid Endometrial Cancer Cell Lines
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2013)
Transcriptional Up-Regulation of Sox9 by NF-κB in Endometrial Carcinoma Cells, Modulating Cell Proliferation Through Alteration in the p14ARF/p53/p21WAF1 Pathway
Makoto Saegusa et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
Brian M. Slomovitz et al.
CLINICAL CANCER RESEARCH (2012)
Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells
Leyla Kavandi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Activation of NF-κB Is a Novel Target of KRAS-Induced Endometrial Carcinogenesis
Yasunari Mizumoto et al.
CLINICAL CANCER RESEARCH (2011)
Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner
Andree Yeramian et al.
LABORATORY INVESTIGATION (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
17-DMAG targets the nuclear factor-κB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition
Erin Hertlein et al.
BLOOD (2010)
High-throughput and single-cell imaging of NF-κB oscillations using monoclonal cell lines
Sina Bartfeld et al.
BMC CELL BIOLOGY (2010)
Resistance to chemotherapy and hormone therapy in endometrial cancer
Parvesh Chaudhry et al.
ENDOCRINE-RELATED CANCER (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
Compensatory IKKα activation of classical NF-κB signaling during IKKβ inhibition identified by an RNA interference sensitization screen
Lloyd T. Lam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
Michael Rugaard Jensen et al.
BREAST CANCER RESEARCH (2008)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Anna V. Galkin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
PIKK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia
Monica Prasad Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Proteasome inhibitors induce death but activate NF-κB on endometrial carcinoma cell lines and primary culture explants
Xavier Dolcet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Real-time imaging of ligand-induced IKK activation in intact cells and in living mice
S Gross et al.
NATURE METHODS (2005)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation
M Broemer et al.
ONCOGENE (2004)
Abnormalities in the NF-κB family and related proteins in endometrial carcinoma
J Pallares et al.
JOURNAL OF PATHOLOGY (2004)
Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappa B/I kappa B pathway
Marie-Eve St-Germain et al.
MOLECULAR CANCER (2004)
Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway
H Sakurai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis
O Millán et al.
ONCOGENE (2003)
Overview: Translating Hsp90 Biology into Hsp90 Drugs
Paul Workman
CURRENT CANCER DRUG TARGETS (2003)
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
AD Basso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90
GQ Chen et al.
MOLECULAR CELL (2002)
Molecular pathology of endometrial hyperplasia and carcinoma
X Matias-Guiu et al.
HUMAN PATHOLOGY (2001)
Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation
J Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
